Olympus Acquires Stryker OP-1 Products, Spawns Biotech Division

Olympus Corp. is forming a new business focused on regenerative medicine product offerings following the Dec. 6 purchase of Stryker Biotech's OP-1 orthopedic bone protein business for $60 million.